AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

683.947

+0.7470.11%

Number of Gainers:19

Number of Losers:5

Number of Flat:21

PE:- -

High:691.975

Open:684.744

Low:682.775

Close:683.200

Volume:36.26M

Turnover:94.15M

Market Cap:102.25B

Float Cap:98.92B

Loading ...

We’re not in Kansas anymore

BUZZ-Australia's October Medicare growth muted; Jefferies holds view on healthcare providers

High Growth Tech Stocks In Australia For November 2025

Simply Wall St.

Proteomics Says US CMS Sets Reimbursement Price for Kidney Disease Predictive Test; Shares Rise 16%

MT Newswires Live

Bioxyne Unit Ships Second GMP MDMA Batch to Victoria

MT Newswires Live

Race Oncology Secures Human Research Ethics Committee Approval for Non-Small Cell Lung Cancer Therapy Candidate Clinical Trial, Shares Fall 8%

MT Newswires Live

BRIEF-Patrys Entered Into Agreement To Acquire Reliis

Patrys Ltd - Entered Into Binding Agreement to Acquire 100% of Reliis Pty Ltd

THOMSON REUTERS

Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live

BRIEF-Mesoblast Expects Gross Revenue Of More Than $30.0 Mln From Sales Of Ryoncil For Quarter Ending Dec 31

Mesoblast Ltd - for Quarter Ending December 31, 2025, Expects Gross Revenue of More Than US$30.0 Million From Sales of Ryoncil

THOMSON REUTERS

oToBrite Unveils Advanced Vision-AI Solutions for Outdoor Robotics and Unmanned Vehicles at iREX 2025 Including the New GMSL™ Camera with indie CVP and Developer Kit for Jetson Platform

swop 2025: Shanghai World of Packaging Grandly Held in November, Marking Its 10th Anniversary

A Fresh Look at Hexcel (HXL) Valuation Following Leadership Transition and CFO Appointment

Simply Wall St.

Monash IVF Group Shares Fall After Washington H. Soul Pattinson Increases Stake in Firm

MT Newswires Live

Deals of the day-Mergers and acquisitions

Analysis of Historical Transaction Multiples Implies AU$1.62 Per Share Valuation for Monash IVF, Jefferies Says

MT Newswires Live

Race Oncology Ltd-Replacement Constitution

THOMSON REUTERS

Cynata Therapeutics Completes Phase 3 SCUIpTOR Trial in Knee Osteoarthritis; Shares Up 6%

MT Newswires Live

Proteomics Says Racehorse Performance Data Confirms Potential of Unit's Stress Testing Technology; Shares Jump 5%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK7508/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":683.94653,"timestamp":1764305999920,"preClose":683.1998,"halted":0,"volume":36263776,"delay":0,"changeRate":0.001093,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":0.746704,"latestTime":"11-28 16:00:00 AEDT","open":684.7437,"high":691.9752,"low":682.7754,"amount":94147851,"amplitude":0.013466,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1764543600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1764284400000,1764306000000]],"turnoverRate":0.001393,"increases":18,"decrements":6,"flats":20,"marketCap":102252356698,"floatMarketCap":98921583918.9375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":691.9752,"amplitude":0.013466,"preClose":683.1998,"low":682.7754,"latestPrice":683.94653,"volume":36263776,"delay":0,"open":684.7437,"prevYearClose":936.801,"prevWeekClose":683.947,"prevMonthClose":683.947,"prevQuarterClose":712.826,"fiveDayClose":654.211,"twentyDayClose":662.953,"sixtyDayClose":747.652,"secType":"PLATE","market":"AU","turnoverRate":0.001393,"marketCap":102252356698,"floatMarketCap":98921583918.9375,"timestamp":1764305999920,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":19,"down":5,"flat":21},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586262069","title":"We’re not in Kansas anymore","url":"https://stock-news.laohu8.com/highlight/detail?id=2586262069","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586262069?lang=en_us&edition=fundamental","pubTime":"2025-11-27 04:15","pubTimestamp":1764188107,"startTime":"0","endTime":"0","summary":"One only needs to glance at a map of the US equity market to determine ‘We’re not in Kansas anymore’. The era of network economics and ever greater financialisation has wrought massive change on equity markets and increasingly on the real economy.Ever-growing government deficits and strong ongoing growth in household borrowing are funding a relatively buoyant profit environment, albeit one that is distributed increasingly unevenly. Disequilibrium is becoming the norm and the economic forces which tended to work against this are proving ineffective. While the reasons for this ongoing disequilibrium are debatable, a few seem important.Keen to display the power of monetary intervention in ‘smoothing’ economic cycles and preventing any downturn, central bankers everywhere have ensured additional credit and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/we-re-not-in-kansas-anymore","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/we-re-not-in-kansas-anymore","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["XAO.AU","MQG.AU","BK7501","MPL.AU","CBA.AU","HLS.AU","BK7135","BK7089","BK7511","RHC.AU","SHL.AU","ACL.AU","XJO.AU","BK7508","BK7113","CSL.AU","XKO.AU","BK7509","BK7124","BK7067","BK7046"],"gpt_icon":0},{"id":"2586478262","title":"BUZZ-Australia's October Medicare growth muted; Jefferies holds view on healthcare providers","url":"https://stock-news.laohu8.com/highlight/detail?id=2586478262","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586478262?lang=en_us&edition=fundamental","pubTime":"2025-11-27 03:26","pubTimestamp":1764185216,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's October Medicare growth muted; Jefferies holds view on healthcare providers** Jefferies says Australia's October Medicare data shows muted growth across pathology and imaging, with ge","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nL6N3X212J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","IDX.AU","HLS.AU","BK7124","MVF.AU","SHL.AU","BK7509","BK7508","BK7113"],"gpt_icon":0},{"id":"2586298746","title":"High Growth Tech Stocks In Australia For November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2586298746","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586298746?lang=en_us&edition=fundamental","pubTime":"2025-11-27 03:05","pubTimestamp":1764183951,"startTime":"0","endTime":"0","summary":"As the Australian market navigates a period of mixed sentiment, with the S&P/ASX 200 (XJO) rebounding to 8,600 points despite inflation climbing to 3.8%, investors are closely watching sectors like IT which recently lagged behind materials. In this environment, identifying high-growth tech stocks requires careful consideration of their resilience and potential catalysts for growth amidst broader economic fluctuations and sector-specific challenges.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-pyc/pyc-therapeutics-shares/news/high-growth-tech-stocks-in-australia-for-november-2025-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-pyc/pyc-therapeutics-shares/news/high-growth-tech-stocks-in-australia-for-november-2025-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XJO.AU","IMM.AU","XKO.AU","XRO.AU","XAO.AU","BK7503","BK7067","PYC.AU","BK7016","BK7508"],"gpt_icon":0},{"id":"2586528032","title":"Proteomics Says US CMS Sets Reimbursement Price for Kidney Disease Predictive Test; Shares Rise 16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586528032","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586528032?lang=en_us&edition=fundamental","pubTime":"2025-11-26 13:00","pubTimestamp":1764133200,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  said the US Centers for Medicare & Medicaid Services set a reimbursement price of $390.75 for Promarker D, the company's predictive test for diabetic kidney disease, effective Jan.1, 2026, according to a Wednesday filing with the Australian bourse.The company will now seek to obtain private health insurer coverage, the filing said.Shares of the company rose 16% in recent Wednesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2637428348.USD","BK7048","LU0949170772.SGD","BK7508","CMS","LU2346227817.USD","LU0553294199.USD","LU1894683348.USD","LU2500361329.USD","BK4585","PIQ.AU","BK4588","BK4208","LU0661504455.SGD","LU1894683264.USD","LU0545039389.USD","LU0738911758.USD","LU1003077747.HKD"],"gpt_icon":0},{"id":"2586110281","title":"Bioxyne Unit Ships Second GMP MDMA Batch to Victoria","url":"https://stock-news.laohu8.com/highlight/detail?id=2586110281","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586110281?lang=en_us&edition=fundamental","pubTime":"2025-11-26 10:53","pubTimestamp":1764125580,"startTime":"0","endTime":"0","summary":"Bioxyne's  Breathe Life Sciences subsidiary dispatched its second shipment of Good Manufacturing Practice  MDMA capsules to the Victorian Government's Eastern Health department, according to a Wednesday filing with the Australian bourse.The shipment will facilitate a clinical trial focused on MDMA-assisted psychotherapy for patients with co-occurring post-traumatic stress disorder and borderline personality disorder, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4095","BK7508","BXN.AU","VCCTF","BK7111"],"gpt_icon":0},{"id":"2586866362","title":"Race Oncology Secures Human Research Ethics Committee Approval for Non-Small Cell Lung Cancer Therapy Candidate Clinical Trial, Shares Fall 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586866362","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586866362?lang=en_us&edition=fundamental","pubTime":"2025-11-26 09:42","pubTimestamp":1764121361,"startTime":"0","endTime":"0","summary":"Race Oncology  received human ethics approval from the St. Vincents Hospital, Melbourne human research ethics committee to begin a phase 1a/b clinical trial assessing the safety, tolerability and pharmacokinetics of its RC220 therapy candidate, in combination with osimertinib, in patients with non-small cell lung cancer that have activating epidermal growth factor receptor mutations, according to a Wednesday Australian bourse filing.Phase 1a will begin with a circulating tumor DNA screening stage, followed by dose escalation, where between 12 and 40 patients will receive intravenous infusion of RC220 on the first day of a 21-day cycle in combination with standard-of-care osimertinib. The study will start with three single-patient cohorts before transitioning to a larger number of patient cohorts to identify the maximum tolerated dose of RC220.In the Phase 1b stage, 40 patients will be randomized to one of two treatment dose levels.Monash Health in Victoria will start enrolling patients","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7067","RAC.AU"],"gpt_icon":0},{"id":"2586128588","title":"BRIEF-Patrys Entered Into Agreement To Acquire Reliis","url":"https://stock-news.laohu8.com/highlight/detail?id=2586128588","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586128588?lang=en_us&edition=fundamental","pubTime":"2025-11-26 09:10","pubTimestamp":1764119448,"startTime":"0","endTime":"0","summary":"BRIEF-Patrys Entered Into Agreement To Acquire ReliisNov 26 (Reuters) - Patrys Ltd PAB.AX:ENTERED INTO BINDING AGREEMENT TO ACQUIRE 100% OF RELIIS PTY LTDFurther company coverage: PAB.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nFWN3X10TA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","PAB.AU","BK7508"],"gpt_icon":0},{"id":"2586740452","title":"Patrys Ltd - Entered Into Binding Agreement to Acquire 100% of Reliis Pty Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2586740452","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586740452?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:15","pubTimestamp":1764108923,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10TA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","PAB.AU"],"gpt_icon":0},{"id":"2586778964","title":"Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2586778964","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586778964?lang=en_us&edition=fundamental","pubTime":"2025-11-26 00:04","pubTimestamp":1764086683,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were tracking lower Tuesday morning, declining 0.72% to 2,621.09 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by fintech firm Qfin  and mobile app developer Cheetah Mobile , which climbed 9.2% and 3% respectively. They were followed by automotive marketplace Token Cat  and mobile healthcare platform 111 , which advanced 4.9% and 4.8% respectively.The decliners from North Asia were led by fintech firms Chaince Digital  and  LexinFintech , which tumbled 14% and  9.1% respectively. They were followed by brand platform Baozun  and computer hardware maker Canaan , which shed 6.9% and 5.4% respectively.From South Asia, the gainers were led by pharmaceutical company Dr. Reddy's Laboratories , which rose 1.7%, followed by telecommunications operator Telekomunikasi Indonesia  and lender ICICI Bank , which were up 0.9% and 0.1% respectively.The decliners from South Asia were led by IT firm Sify Technologies  an","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INFY","LU2125910849.SGD","BZUN","TLK","LU0516423091.SGD","LU0589944569.HKD","AFG","QFIN","RDY.AU","LU1791710582.SGD","BK4558","BK4509","LU0821914370.USD","SG9999013460.SGD","IBN","LU0345776255.USD","BK4107","CD","LU1861217088.USD","LU0048573645.USD","RDY","IE00B7N09G41.SGD","LU2065171402.SGD","CAN.AU","LU0231203729.USD","BK4085","BK7508","LU1267930656.SGD","BK7096","LU0499858602.USD","LU0633140560.USD","LU0831103253.SGD","BK4548","LU1808992512.USD","LU0456842615.SGD","BK4023","SG9999002406.SGD","SIFY","YI","BK4128","LU1508157978.USD","BK4588","TC","CMCM","LX","SG9999013478.USD","HDB","LU2065171311.SGD"],"gpt_icon":1},{"id":"2586474997","title":"BRIEF-Mesoblast Expects Gross Revenue Of More Than $30.0 Mln From Sales Of Ryoncil For Quarter Ending Dec 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2586474997","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586474997?lang=en_us&edition=fundamental","pubTime":"2025-11-25 23:08","pubTimestamp":1764083338,"startTime":"0","endTime":"0","summary":"BRIEF-Mesoblast Expects Gross Revenue Of More Than $30.0 Mln From Sales Of Ryoncil For Quarter Ending Dec 31 Nov 25  - Mesoblast Ltd MSB.AX:MESOBLAST LTD - FOR QUARTER ENDING DECEMBER 31, 2025, EXPECTS GROSS REVENUE OF MORE THAN US$30.0 MILLION FROM SALES OF RYONCILSource text: [ID:n0001345099-25-000101]Further company coverage: MSB.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7501","BK7067","BK4139","MESO","MSB.AU"],"gpt_icon":0},{"id":"2586471162","title":"Mesoblast Ltd - for Quarter Ending December 31, 2025, Expects Gross Revenue of More Than US$30.0 Million From Sales of Ryoncil","url":"https://stock-news.laohu8.com/highlight/detail?id=2586471162","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586471162?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:44","pubTimestamp":1764081869,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","BK4139","MESO","BK7501","MSB.AU"],"gpt_icon":0},{"id":"2586476959","title":"oToBrite Unveils Advanced Vision-AI Solutions for Outdoor Robotics and Unmanned Vehicles at iREX 2025 Including the New GMSL™ Camera with indie CVP and Developer Kit for Jetson Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2586476959","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586476959?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:35","pubTimestamp":1764077700,"startTime":"0","endTime":"0","summary":"HSINCHU, Nov. 25, 2025 /PRNewswire/ -- As a proven provider of complete Vision-AI solutions for the automotive and robotics markets,oToBrite will unveila portfolio of next-generation visual perception technologies at iREX 2025. The showcase features the automotive-grade GMSL2 camera series, the VIO  camera, the oToSLAM multi-camera Vision-AI positioning system, and the new GMSL Camera Jetson Developer Kit—demonstrating strong capabilities in automotive imaging, sensor fusion, and AI-driven perception for outdoor robotics, UGVs, humanoid robots, and next-generation smart mobility applications.oToBritewill introduce its developer kits designed specifically for the Jetson AGX Orin and Jetson Orin Nano. These solutions accelerate multi-camera vision development on Jetson platforms. The oToAdapter-GMSL-AGX-Orin supports up to eight GMSL2 cameras with 275 TOPS of AI performance, while the oToAdapter-GMSL-Orin-Nano supports up to four cameras with 67 TOPS—both offering plug-and-play integrati","market":"other","thumbnail":"https://mma.prnewswire.com/media/2830717/irex.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2830717/irex.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/otobrite-unveils-advanced-vision-ai-solutions-for-outdoor-robotics-and-unmanned-vehicles-at-irex-2025-including-the-new-gmsl-camera-with-indie-cvp-and-developer-kit-for-jetson-platform-302625704.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4528","SG9999002950.SGD","AI","IMU.AU","SG9999004360.SGD","BK7508","BK4588","BK6102","BK4023","BK7067","BK4551","SG9999001069.SGD","BK4585","A7RU.SI","BK4543","BK6501","SG9999003461.SGD","BK6031","SG9999003826.SGD","BK4587"],"gpt_icon":0},{"id":"2586255423","title":"swop 2025: Shanghai World of Packaging Grandly Held in November, Marking Its 10th Anniversary","url":"https://stock-news.laohu8.com/highlight/detail?id=2586255423","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586255423?lang=en_us&edition=fundamental","pubTime":"2025-11-25 17:00","pubTimestamp":1764061200,"startTime":"0","endTime":"0","summary":"SHANGHAI, Nov. 25, 2025 /PRNewswire/ -- The Shanghai World of Packaging , co-organized byMesse Düsseldorf  Co., Ltd. and Adsale Exhibition Services Ltd., took place from November 25–27, 2025, at SNIEC .swop 2025 concentrated on core packaging themes — artificial intelligence and digital packaging; sustainable materials and circular design; and lightweight and customized solutions. The exhibition delivered a systematic, one-stop industry-chain showcase spanning processing and packaging machinery, material innovation, packaging products, label printing, and packaging design. The 2025 edition set a new scale record: exhibition space exceeded 70,000 square meters, and the show brought together over 950 exhibitors from around the world, featuring international pavilions from Germany, Italy, Austria, France, Turkey, Switzerland, Japan, and South Korea. Over the three-day period, the exhibition was expected to draw more than 40,000 trade visitors and buyers from China and abroad to Shanghai.A","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/swop-2025-shanghai-world-of-packaging-grandly-held-in-november-marking-its-10th-anniversary-302625409.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","BK7508","BK7067","MDC.AU","PTA"],"gpt_icon":0},{"id":"2586443622","title":"A Fresh Look at Hexcel (HXL) Valuation Following Leadership Transition and CFO Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2586443622","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586443622?lang=en_us&edition=fundamental","pubTime":"2025-11-25 10:12","pubTimestamp":1764036770,"startTime":"0","endTime":"0","summary":"Hexcel (HXL) is undergoing a leadership transition, as Chief Financial Officer Patrick Winterlich is stepping down at the end of November. Michael C. Lenz, with a background at FedEx, will serve as interim CFO while the search for a permanent replacement is conducted.\nSee our latest analysis for Hexcel.\nHexcel’s recent leadership shakeup comes amid an upswing in price momentum, with the share price advancing by 18.01% year-to-date and a 14.74% gain in the past quarter. While executive...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3021000-choice1-main-header/1585186644732","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3021000-choice1-main-header/1585186644732"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-hxl/hexcel/news/a-fresh-look-at-hexcel-hxl-valuation-following-leadership-tr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-hxl/hexcel/news/a-fresh-look-at-hexcel-hxl-valuation-following-leadership-tr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0205194284.USD","LU0053671581.USD","BK7508","BK4187","LU0205193047.USD","HXL","BK7067","LU0240878834.USD","HXL.AU","LU0240877869.USD"],"gpt_icon":0},{"id":"2586041736","title":"Monash IVF Group Shares Fall After Washington H. Soul Pattinson Increases Stake in Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2586041736","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586041736?lang=en_us&edition=fundamental","pubTime":"2025-11-25 09:50","pubTimestamp":1764035421,"startTime":"0","endTime":"0","summary":"Shares of Monash IVF Group  fell nearly 3% in recent trading on Tuesday after it said in an ASX filing late on Monday that Washington H. Soul Pattinson and Co.  increased its stake in the firm to 19.6% from 9.69% previously.Monash had rejected a proposal from a consortium holding a 19.6% stake and consisting of Genesis Capital Investment Management and WHSP Holding to acquire the company's shares for AU$0.80 per share via a scheme of arrangement.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1670711040.USD","BK4202","MVF.AU","SOL.AU","LU1670711123.USD","VFC","BK7105","BK4588","IVF","LU1670710588.SGD","BK7083","BK7113","BK4082","BK4504","WASH","BK4585","LU1670710661.SGD","BK4211","BK7508"],"gpt_icon":0},{"id":"2585306466","title":"Deals of the day-Mergers and acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2585306466","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585306466?lang=en_us&edition=fundamental","pubTime":"2025-11-24 19:07","pubTimestamp":1763982438,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsNov 24  - The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Monday:** BHP <BHP.AX> abandoned a last-ditch effort to buy rival Anglo American <AAL.L> and bolster its dominance in copper, just two weeks before Anglo and Teck Resources' shareholders were set to vote on a $60 billion merger.nL1N3WZ080** Monash IVF Group <MVF.AX> said it had rejected an offer from a consortium that valued the Australian fertility services provider at A$311.7 million , sending its shares soaring to a six-month high.nL4N3X000M** Qube Holdings <QUB.AX> said that Macquarie Asset Management, a unit of Macquarie <MQG.AX>, submitted a non-binding proposal to acquire all issued shares of Qube for A$5.20 in cash per share, valuing the company at A$11.6 billion , including debt.nL1N3WZ082   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nL6N3X00D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0654597011.USD","LU0505663152.USD","LU0171293334.USD","LU0266512127.USD","LU0612318971.USD","QUB.AU","BHP.AU","LU0054450605.USD","BK7508","AAL.UK","LU2023250504.SGD","MVF.AU","SG9999002521.SGD","LU2106854487.HKD","LU1015430645.USD","BK7046","BK4588","TECK","BK7079","LU0449515922.USD","LU0575583348.USD","LU0456854461.SGD","LU0161305163.EUR","LU0321505868.SGD","BK5111","LU0330918003.SGD","LU1430597077.USD","LU0075056555.USD","LU0321505439.SGD","BK4168","BK4591","BK7507","BK7113","MQG.AU","BK4585","LU0345781412.USD","LU0630314457.HKD","BK7511","LU0345780950.USD","LU1974910355.USD","IE00BSNM7G36.USD","LU1023059493.AUD","LU1917777945.USD","LU0612318385.USD","BK7095","LU0788109121.HKD"],"gpt_icon":0},{"id":"2585550984","title":"Analysis of Historical Transaction Multiples Implies AU$1.62 Per Share Valuation for Monash IVF, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2585550984","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585550984?lang=en_us&edition=fundamental","pubTime":"2025-11-24 14:48","pubTimestamp":1763966925,"startTime":"0","endTime":"0","summary":"The average last twelve months enterprise value to earnings before interest, taxes, depreciation, and amortization ratio  for comparable in vitro fertilization assets of 13.8x implies a valuation for Monash IVF Group  of AU$1.62 per share, Jefferies said in a Monday note.Monash IVF rejected a proposal from a consortium, holding a 19.6% stake and consisting of Genesis Capital Investment Management and WHSP Holding, to acquire the company's shares for AU$0.80 per share via a scheme of arrangement.Monash IVF said that the offer materially undervalues the company and is not in the best interest of shareholders.It guided to a fiscal year 2026 first half underlying net profit after tax of AU$10 million to AU$10.5 million. It also guided to a fiscal 2026 underlying net profit after tax to the bottom end of the previously guided AU$20 million to AU$23 million.Declines in new patient registrations and domestic Monash IVF stimulated cycles led to EBITDA margins declining by 300 basis points comp","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IVF","BK4082","MVF.AU","BK7508","BK7113"],"gpt_icon":0},{"id":"2585437206","title":"Race Oncology Ltd-Replacement Constitution","url":"https://stock-news.laohu8.com/highlight/detail?id=2585437206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585437206?lang=en_us&edition=fundamental","pubTime":"2025-11-24 11:56","pubTimestamp":1763956598,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nTUE3S1NXC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAC.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2585437297","title":"Cynata Therapeutics Completes Phase 3 SCUIpTOR Trial in Knee Osteoarthritis; Shares Up 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585437297","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585437297?lang=en_us&edition=fundamental","pubTime":"2025-11-24 11:52","pubTimestamp":1763956350,"startTime":"0","endTime":"0","summary":"Cynata Therapeutics  completed the final participant visits in its pivotal phase 3 SCUIpTOR trial of CYP-004 for knee osteoarthritis, marking the end of the two-year follow-up, according to a Monday filing with the Australian bourse.The University of Sydney will complete data monitoring and quality checks, with the trial results anticipated in the second quarter of 2026, the filing added.The company's shares rose around 6% in recent Monday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CYP.AU","BK4139","BK4007","LENZ","BK4539","BK7508","BK7501","BK7067"],"gpt_icon":0},{"id":"2585437143","title":"Proteomics Says Racehorse Performance Data Confirms Potential of Unit's Stress Testing Technology; Shares Jump 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585437143","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585437143?lang=en_us&edition=fundamental","pubTime":"2025-11-24 11:47","pubTimestamp":1763956054,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  said performance data on Australian thoroughbred racehorses supports the potential of its OxiDx unit's oxidative stress testing technology in providing insight into the physiological readiness of racehorses, according to a Monday filing with the Australian bourse.New findings gathered using the OxiDx test showed that thoroughbred horses racing without oxidative stress were 76% more likely to place and 49% more likely to win than horses with oxidative stress, the filing said.Horses racing without oxidative stress increased the likelihood of winning or placing in the top three, the filing added.Shares of the company rose 5% in recent Monday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","XJO.AU","BK7048","BK7508","XAO.AU","PIQ.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":141,"code":"91000000","status":"200"}]}}